We are studying whether a new medication can help prevent diabetes in patients immediately after receiving a kidney transplant. This trial looks at various health effects and safety over time.
Health conditions and diseases that the clinical trial is designed to study and treat.
Post-Kidney Transplant Diabetes (PTDM) is a condition that can develop in patients after receiving a kidney transplant, characterized by high blood sugar levels due to the effects of immunosuppressive medications and changes in metabolism.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.